harvard medical school coronary mdcta applications thomas h. hauser md, mmsc, mph, facc director of...

56
Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center Assistant Professor of Medicine Harvard Medical School Boston, MA

Upload: monica-thwaites

Post on 01-Apr-2015

214 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Coronary MDCTA Applications

Thomas H. Hauser

MD, MMSc, MPH, FACCDirector of Nuclear Cardiology

Beth Israel Deaconess Medical CenterAssistant Professor of Medicine

Harvard Medical SchoolBoston, MA

Page 2: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Outline

• Possible indications for coronary MDCTA• How to approach a coronary MDCTA study

Page 3: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Outline

• Possible indications for coronary MDCTA• How to approach a coronary MDCTA study

Page 4: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Possible Indications for Cardiac CT

• Coronary artery – CAD/Plaque

– Stents

– Grafts

– Anomalous coronaries

• Ventricular size and function

• Valve imaging

• Myocardial perfusion

• Infarct imaging• Cardiac vein imaging

• Congenital heart disease

• Cardiac masses

• Cardiomyopathy

• Pulmonary vein imaging

Page 5: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Detection of CAD

Accuracy investigators, RSNA 2007

Page 6: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Clinical Evaluation of

Coronary CTA

Page 7: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Multi-Center Trial: 16-Slice MDCT

Garcia, M. J. et al. JAMA 2006;296:403-411.

Page 8: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Multi-Center Trials: CORE-64, Accuracy

• CORE-64 reported at AHA 2007 (Toshiba)– 291 patients at 9 institutions

– Sensitivity 85%

– Specificity 90%

– Excluded patients with calcium score >600

• ACCURACY reported at RSNA 2007 (GE)– 229 patients at 16 institutions

– Sensitivity 93%

– Specificity 82%

Page 9: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

ACCURACY Trial

J Am Coll Cardiol Budoff et al. online only

Page 10: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Limitations of Coronary CTA

• Coronary Motion • Slab artifacts

– Ventricular Ectopy

– Ventilatory Motion

• Calcium• Stents• Radiation Dose

Page 11: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Coronary Motion

Hoffmann et al, J Nucl Med 2006; 47:797–806

Page 12: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Higher Heart Rate = More Motion

Hoffmann, M. H. K. et al. Radiology 2005;234:86-97

Page 13: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Slab Artifact

Hoffmann et al, J Nucl Med 2006; 47:797–806

Page 14: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Calcium

Hoffmann et al, J Nucl Med 2006; 47:797–806

Page 15: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Calcium

Raff et al, J Am Coll Cardiol 2005;46:552–7

Page 16: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Stents

Gaspar, T. et al. J Am Coll Cardiol 2005;46:1573-1579

Page 17: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Stents

Page 18: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Grafts

Page 19: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Grafts

Page 20: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Grafts

Page 21: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Grafts

Page 22: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Grafts

Vessels Segments Sens Spec

Grafts 109 182 99% 96%

Run-off 109 123 89% 93%

Non-BP 116 288 97% 86%

Malagutti et al. Eur Heart J 2006 epub

Page 23: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Radiation Dose: High

Einstein et al, JAMA. 2007;298:317-323.

Page 24: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Radiation Dose

J Am Coll Cardiol Maruyama et al. 52 (18): 1450

Page 25: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Radiation Dose

J Am Coll Cardiol Maruyama et al. 52 (18): 1450

Page 26: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Problems Correlating with Angiography

• Angiographic stenosis is not perfectly correlated with functional significance– Potential advantages for combining with functional

imaging

• Identification of non-obstructive plaque may identify patients at increased risk for adverse events– Ongoing prospective studies of prognosis

Page 27: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Angiographic vs. Functional Stenosis

Meijboom et al, J Am Coll Cardiol, 2008; 52:636-643

Page 28: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Outcomes after CTA

Ostrom et al, J Am Coll Cardiol, 2008; 52:1335-1343

Page 29: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Plaque Characterization

Leber et al, J Am Coll Cardiol, 2005; 46:147-154

Page 30: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Anomalous Coronary Arteries

http://bhavin.typepad.com/cardiac_images/

Page 31: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Anomalous Coronary Arteries

http://bhavin.typepad.com/cardiac_images/

Page 32: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Ventricular Function

Page 33: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Ventricular Function

Page 34: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Ventricular Function: Compared to CMR

Segung et al, Circulation 2006;114:654-661; 31 patients

Page 35: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Ventricular Function: Compared to CMR

Segung et al, Circulation 2006;114:654-661; 31 patients, radial method

Page 36: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Valvular Function

http://bhavin.typepad.com/cardiac_images/

Page 37: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Valvular Function

http://bhavin.typepad.com/cardiac_images/

Page 38: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Aortic Stenosis

Pouleur et al, Radiology 2007;244:745-754

Page 39: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Aortic Stenosis

Pouleur et al, Radiology 2007;244:745-754

Page 40: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Aortic Stenosis

Pouleur et al, Radiology 2007;244:745-754

Agreement between multidetector CT and TTE in the detection of normal (AVA 2 cm2), mildly stenotic (AVA 1.2 cm2 and < 2.0 cm2),

moderately stenotic (AVA 0.8 cm2 and < 1.2 cm2), or severely stenotic (AVA < 0.8 cm2) aortic valve opening was excellent ( = 0.88, P < .001)

Page 41: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Valvular Function

Page 42: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Valvular Dehiscence

Page 43: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Valvular Dehiscence

Page 44: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Perfusion and Late Enhancement

Nieman et al. Radiology.2008; 247: 49-56

Page 45: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Perfusion and Late Enhancement

Nieman et al. Radiology.2008; 247: 49-56

Page 46: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Perfusion and Late Enhancement

Nieman et al. Radiology.2008; 247: 49-56

Page 47: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Cardiac CT

• Possible indications for coronary MDCTA• How to approach a coronary MDCTA study

Page 48: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

How to Review a Coronary CTA Study

• Review the axial images– Interrogate multiple reconstructions at different points in the

cardiac cycle to determine which has the least amount of artifact

• If any abnormalities, further investigate them with MIPs MPRs, and curved MPRs.

• Volume rendered images can be helpful to communicate your findings– Generally not diagnostic– Especially helpful in graft cases

• The entire dataset beyond the heart needs to be reviewed to ensure that there are no other significant findings.

Page 49: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Axial Stack

Page 50: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Axial Slice

Page 51: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

MIP

Page 52: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Volume Rendered Image

Page 53: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

cMPR with SAX and VA

Page 54: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

cMPR with SAX and VA, Orthogonal

Page 55: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Importance of Interactive Reconstructions

Ferencik et al, Radiology: Volume 243: Number 3—June 2007

Page 56: Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center

Harvard Medical School

Outline

• Possible indications for coronary MDCTA– Coronary artery imaging is becoming established

• Stenosis

• Plaque characterization

• Stents

• Grafts

– Ventricular function

– Aortic Stenosis

• How to approach a coronary MDCTA study– Axial images contain all of the primary data

– Use interactive reconstructions to aid in assessing problem areas